VISTAGEN THERAPEUTICS INC (VTGN) Stock Analyst Ratings
NASDAQ:VTGN - Nasdaq - US92840H4002 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 88% to VTGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.26. This target is 380.43% above the current price.
VTGN was analyzed by 10 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VTGN.
In the previous month the buy percentage consensus was at a similar level.
VTGN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-14 | Stifel | Initiate | Buy |
| 2023-09-05 | Maxim Group | Maintains | Buy -> Buy |
| 2023-08-07 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-05-20 | Baird | Initiate | Outperform |
| 2021-02-18 | Jefferies | Initiate | Buy |